CN107936008B - 氘代化合物及其医药用途 - Google Patents
氘代化合物及其医药用途 Download PDFInfo
- Publication number
- CN107936008B CN107936008B CN201610890151.8A CN201610890151A CN107936008B CN 107936008 B CN107936008 B CN 107936008B CN 201610890151 A CN201610890151 A CN 201610890151A CN 107936008 B CN107936008 B CN 107936008B
- Authority
- CN
- China
- Prior art keywords
- addiction
- compound
- pharmaceutically acceptable
- pain
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (5)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610890151.8A CN107936008B (zh) | 2016-10-13 | 2016-10-13 | 氘代化合物及其医药用途 |
EP17861072.1A EP3517537B1 (en) | 2016-10-13 | 2017-09-22 | Deuterated derivative of l-tetrahydropalmatine and medical use thereof |
PCT/CN2017/000607 WO2018068429A1 (zh) | 2016-10-13 | 2017-09-22 | 左旋四氢帕马汀氘代衍生物及其医药用途 |
JP2019541837A JP7050336B2 (ja) | 2016-10-13 | 2017-09-22 | 重水素化化合物及びその医薬的用途 |
US16/383,307 US10617679B2 (en) | 2016-10-13 | 2019-04-12 | Deuterated compounds and medical uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610890151.8A CN107936008B (zh) | 2016-10-13 | 2016-10-13 | 氘代化合物及其医药用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107936008A CN107936008A (zh) | 2018-04-20 |
CN107936008B true CN107936008B (zh) | 2022-06-14 |
Family
ID=61905096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610890151.8A Active CN107936008B (zh) | 2016-10-13 | 2016-10-13 | 氘代化合物及其医药用途 |
Country Status (5)
Country | Link |
---|---|
US (1) | US10617679B2 (zh) |
EP (1) | EP3517537B1 (zh) |
JP (1) | JP7050336B2 (zh) |
CN (1) | CN107936008B (zh) |
WO (1) | WO2018068429A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111184719B (zh) * | 2020-01-17 | 2023-02-28 | 上海交通大学 | 一种多巴胺受体拮抗剂及其用途 |
CN113354634A (zh) * | 2020-03-06 | 2021-09-07 | 中国科学院化学研究所 | 化合物及含有其的药物组合物和在治疗脑瘤中的用途 |
CN115260185A (zh) * | 2022-08-02 | 2022-11-01 | 杨征 | 金黄紫堇碱和千金藤啶碱的氘代衍生物及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1483407A (zh) * | 2002-09-18 | 2004-03-24 | 中国人民解放军军事医学科学院毒物药 | 用于镇痛和戒毒的含罗通定的药物组合物 |
KR20100064512A (ko) * | 2008-12-05 | 2010-06-15 | 대한민국 (식품의약품안전청장) | L-thp를 유효성분으로 포함하는 약물남용 치료제 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5019788A (zh) * | 1973-06-25 | 1975-03-01 | ||
DK2326643T3 (da) | 2008-09-18 | 2013-08-05 | Auspex Pharmaceuticals Inc | Benzoquinolin-inhibitorer fra vesikulær monoamin-transporter 2 |
CN103520010A (zh) * | 2013-10-18 | 2014-01-22 | 柳州两面针股份有限公司 | 延胡索乙素与柚皮苷在制备口腔护理品中的应用 |
-
2016
- 2016-10-13 CN CN201610890151.8A patent/CN107936008B/zh active Active
-
2017
- 2017-09-22 EP EP17861072.1A patent/EP3517537B1/en active Active
- 2017-09-22 JP JP2019541837A patent/JP7050336B2/ja active Active
- 2017-09-22 WO PCT/CN2017/000607 patent/WO2018068429A1/zh unknown
-
2019
- 2019-04-12 US US16/383,307 patent/US10617679B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1483407A (zh) * | 2002-09-18 | 2004-03-24 | 中国人民解放军军事医学科学院毒物药 | 用于镇痛和戒毒的含罗通定的药物组合物 |
KR20100064512A (ko) * | 2008-12-05 | 2010-06-15 | 대한민국 (식품의약품안전청장) | L-thp를 유효성분으로 포함하는 약물남용 치료제 |
Non-Patent Citations (2)
Title |
---|
2H和3H标记四氢小檗碱的制备;章辛 等;《核技术》;19880430;第11卷(第4期);24-26 * |
罗通定治疗***依赖者稽延性戒断症状的临床疗效观察;卢咏泉 等;《中国药物滥用防治杂志》;20160731;第22卷(第4期);205-207 * |
Also Published As
Publication number | Publication date |
---|---|
US20190240204A1 (en) | 2019-08-08 |
CN107936008A (zh) | 2018-04-20 |
US10617679B2 (en) | 2020-04-14 |
EP3517537B1 (en) | 2023-09-13 |
JP2019531353A (ja) | 2019-10-31 |
JP7050336B2 (ja) | 2022-04-08 |
EP3517537A4 (en) | 2020-05-27 |
WO2018068429A1 (zh) | 2018-04-19 |
EP3517537A1 (en) | 2019-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106967070A (zh) | 作为jak抑制剂的化合物 | |
CN107936008B (zh) | 氘代化合物及其医药用途 | |
CN100545164C (zh) | 斑蝥酸钠的制备工艺 | |
CN107686482A (zh) | 新型七环化合物,其合成,活性评价及应用 | |
CN112574098B (zh) | 一种酰胺化合物及其制备方法和用途 | |
CN103906749A (zh) | 原小檗碱类生物碱衍生物及其抗溃疡性结肠炎的用途 | |
CN101434635B (zh) | 一类具抗肿瘤活性的水溶性酚性三萜化合物及其制备方法 | |
CN114948953A (zh) | 一种杂原子取代芳香类化合物及其盐的用途 | |
CN111712491A (zh) | 四氢异喹啉类化合物、其制备方法、包含此类化合物的药物组合物及其用途 | |
EA017627B1 (ru) | Хинуклидиновые производные в качестве антагонистов мускаринового м3 рецептора | |
US10759809B2 (en) | Deuterated compound and medical use thereof | |
CN102617584B (zh) | 一种盐酸伊立替康化合物及其药物组合物 | |
CN114644642B (zh) | 一种噻吩并吡啶化合物的晶型a、制备方法及其药物组合物 | |
CN109575008B (zh) | Fxr受体激动剂 | |
CN106963766B (zh) | 一种氮杂螺酮类药物组合物及其制备方法 | |
EP3279198B1 (en) | Crystal form of n-[6-(cis form-2,6-dimethylmorpholine-4-group)pyridine-3- group]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3- formamide monophosphate, and preparation method therefor | |
IE46171B1 (en) | N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives | |
CN110698491B (zh) | 2-(喜树碱-10-氧基)乙酰胺类化合物和应用 | |
CN103193857B (zh) | 止泻木生物碱衍生物及其用途 | |
CN106977561B (zh) | Sutherlandin-5-p-hydroxybenzoate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN106977560B (zh) | 2S-cardiospermin-5-benzoate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN101633661A (zh) | 制备斑蝥酸钠的工艺 | |
WO2002078711A1 (fr) | Medicaments contre l'hyperesthesie vesicale | |
CN106974923B (zh) | Sutherlandin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN106974924B (zh) | Isocardiospermin-5-p-hydroxybenzoate的制备及其在制备治疗类风湿关节炎药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190513 Address after: 101503 Room 223-2131, 142 Huasheng Road, Beizhuang Village, Beizhuang Town, Miyun District, Beijing Applicant after: Jinglu Latitude Information Consulting (Beijing) Co., Ltd. Address before: 225312 Room 707, Building D, Phase II, New Drug Creation Base, No. 1 Yaocheng Avenue, Taizhou City, Taizhou City, Jiangsu Province Applicant before: Taizhou Huayuan Medicine Technology Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200707 Address after: Room 1412, building D, phase II, new drug development base, No.1 Yaocheng Avenue, Taizhou City, Jiangsu Province (east side of Chuangye road and north side of Yuannan Road) Applicant after: JINGLUWEIDAI INFORMATION CONSULTING SERVICE (BEIJING) Co.,Ltd. Address before: 101503 Room 223-2131, 142 Huasheng Road, Beizhuang Village, Beizhuang Town, Miyun District, Beijing Applicant before: Jinglu Latitude Information Consulting (Beijing) Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |